Preclinical Atherosclerosis, Global Cardiovascular Risk and Cardiovascular Events

Indexed in: Book Citation Index, Science Edition (BKCI-S), Web of Science, Scopus, EBSCO.

The simple assessment of atherosclerotic risk factors is not an accurate tool to predict the risk of cardiovascular disease (CVD) in adults without past history of atherosclerotic disease. ...
[view complete introduction]

US $

*(Excluding Mailing and Handling)

The Treatment of Patients with Preclinical Atherosclerosis

Pp. 55-58 (4)

S. Novo, G.R. Amoroso, F. Bonura, P. Carità, E. Corrado and G. Novo


Several clinical trials have focused on the effectiveness of antihypertensive drugs on carotid lesions and CV outcome. In the last years, it has also been shown that statins induce a reduction in the progression rate of carotid IMT and the stabilization of the atherosclerotic plaques.


Preclinical atherosclerosis, anti-hypertensive therapy, statins, literature evidences.


Department of Internal Medicine and Cardiovascular Diseases, University of Palermo – Italy